@article{3046160,
    title = "POLYMORPHONUCLEAR LEUKOCYTE FUNCTIONS AND MULTIPLE-SCLEROSIS",
    author = "PODIKOGLOU, DG and LIANOU, PE and TSAKANIKAS, CD and PAPAVASSILIOU, JT",
    journal = "Functional Neurology",
    year = "1994",
    volume = "44",
    number = "1",
    pages = "129-132",
    publisher = "LITTLE BROWN CO",
    doi = "10.1212/WNL.44.1.129",
    abstract = "We tested peripheral blood from 60 patients with definite multiple
sclerosis (MS) and 60 healthy controls for polymorphonuclear leukocyte
(PMNL) functions and found significant disorders in adherence (9.07%
+/- 8.18% far patients versus 28.97% +/- 5.76% for controls),
chemotaxis (18.32 +/- 3.1 for patients versus 30.49 +/- 4.52 for
controls), phagocytosis (73.6 +/- 25.25 for patients versus 111.2 +/-
25.7 for controls), and bactericidal action (10.35% +/- 5% for
patients versus 25.09% +/- 4.82% for controls). All differences were
significant (p < 0.001). We confirmed the results by retesting 3 to 8
months later. The depressed PMNL functions in MS patients may explain
their increased susceptibility to infections of the respiratory,
digestive, and urinary tracts."
}